Schulte-Sasse, Hermann (Bremen 201008 Staatsrat before BGM) |
Administrative Officer (personnel) |
Bremen (govt region) |
Germany |
Schultheiss, Luc (Endress+Hauser 201309 CFO) |
Chief Financial Officer (CFO) |
Endress+Hauser (Group) |
Switzerland |
Schultheiß, Sebastian J. (Computomics 201301 Managing Director + Co-founder) |
Managing Director |
Computomics (Group) |
Germany |
Schultz-Zehden, Angela (s.Pro GmbH 201204 Managing Director + Founder) |
Managing Director |
s.Pro – sustainable projects GmbH |
Germany |
Schultze, Ute (Optimare 201204 Sales Analytics) |
Sales Manager / Marketing Manager |
Aerodata (Group) |
Germany |
Schulz, Arne (MoBiTec 200809) |
n. a. |
MoBiTec GmbH |
Germany |
Schulz, Gregor (Biotest 201212 CEO) |
Chief Executive Officer (CEO) |
Creat (Group) |
Germany |
Schulz, Olaf (Ametek 201009 Product Manager ICP-OES at SPECTRO) |
Product Manager (personnel) |
AMETEK (Group) |
Germany |
Schulz, Thomas (Hannover Medical School MHH 200606) |
n. a. |
MHH (Hanover Medical School / Medizinische Hochschule Hannover) |
Germany |
Schulz, Wolfgang (Zweckverband Landeswasserversorgung in Langenau 201504) |
n. a. |
Zweckverband Landeswasserversorung (Baden-Württemberg / Bayern) |
Germany |
Schulz-Drost, Michael (Siemens Business Services 200608) |
n. a. |
Siemens (Group) |
Germany |
Schulz-Knappe, Peter (Protagen 201001– head Protein Services before Proteome Sciences plc CEO before BioVisioN CEO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Oncimmune (Group) |
Germany |
Schulze Vohren, Rita (BBM Vohren 2004–) |
n. a. |
BBM Vohren Gesellschaft für Beratung, Beteiligung und Management mbH |
Germany |
Schulze Vohren, Rudolf (BBM Vohren 2004– before Bayer) |
n. a. |
BBM Vohren Gesellschaft für Beratung, Beteiligung und Management mbH |
Germany |
Schulze, Andreas J. (Dualsystems Biotech 201306 CEO before CBO before DEWB + Epidauros Interim CEO + Board) |
Chief Executive Officer (CEO) |
Dualsystems Biotech (Group) |
Switzerland |
Schulze, Frank (Biotest 200908 EVP Global Business Unit Microbiology) |
President/Director/Head Business Group/Unit/Division |
Creat (Group) |
Germany |
Schulze, Jürgen (Sysmex 201401 Managing Director of Sysmex Turkey) |
Managing Director |
Sysmex (Group) |
Turkey |
Schulze, Michael (Biotype 200502) |
n. a. |
Biotype Diagnostic GmbH |
Germany |
Schulze, Rainer (Optimare 201211 Head Business Division Analytics) |
President/Director/Head Business Group/Unit/Division |
Aerodata (Group) |
Germany |
Schulze, Stefan (GME Medical Engineering GmbH 201112 Managing Director) |
Managing Director |
GME Medical Engineering GmbH |
Germany |
Schulze, Stefan (Vifor Pharma 201911 COO + President of Executive Committee) |
Chief Operating Officer (COO) |
Vifor Pharma (Group) |
Switzerland |
Schulze, Svenja (NRW (govt) 201308 Minister of Innovation, Science + Research) |
Minister |
Nordrhein-Westfalen (govt region) |
Germany |
Schulze, Thomas (Avontec 200307– Managing Director before november AG + Bayer AG) |
Managing Director |
Avontec GmbH |
Germany |
Schumacher, Dominik (Tubulis 201907– Managing Director (CEO) + Co-Founder) |
Managing Director |
Tubulis GmbH |
Germany |
Schumacher, Jürgen (Algiax 201104– CEO before NewLab BioQuality 200105 CEO + founder + Qiagen founder) |
Chief Executive Officer (CEO) |
Algiax Pharmaceuticals GmbH |
Germany |
Schumacher, Richard T. (Pressure BioSciences Inc 200703 CEO + founder) |
Chief Executive Officer (CEO) |
Pressure BioSciences Inc. (OTCQB: PBIO) |
United States (USA) |
Schunk, Markus (AstraZeneca 201809– COO at Definiens before CEO at Holtzbrinck Digital joined Holtzbrinck 2004 + KPMG) |
Chief Operating Officer (COO) |
AstraZeneca (Group) |
Germany |
Schuricht, Jan (abcr GmbH 201809 Managing Director) |
Managing Director |
abcr GmbH |
Germany |
Schuster, Steffen (ITM Isotopen Technologien München 201603 CEO) |
Chief Executive Officer (CEO) |
ITM Isotopen Technologien München AG |
Germany |
Schuth, Alexander (Alex) (Denali Therapeutics 201608 COO) |
Chief Operating Officer (COO) |
Denali Therapeutics (Group) |
United States (USA) |
Schutte, Eliane (Xeltis 202005 CEO) |
Chief Executive Officer (CEO) |
Xeltis (Group) |
Switzerland |
Schwab, Andrew (5AM Ventures 200701 founder + Managing Partner) |
Managing Partner (investment firm) |
5AM Ventures (US) |
United States (USA) |
Schwab, Martin E. (NovaGo Therapeutics 201903 President + Founder) |
President/Director/Head Business Group/Unit/Division |
NovaGo Therapeutics AG |
Switzerland |
Schwabe, Matthias (GPM 201402 Head of Working Group PM HealthCare) |
n. a. |
GPM Deutsche Gesellschaft für Projektmanagement e. V. |
Germany |
Schwabe, Wolfgang (Synlab 201004 Managing Director Oncoscreen GmbH) |
Managing Director |
Synlab (Group) |
Germany |
Schwan, Severin (Roche 2008 CEO before CEO of division Roche Diagnostics) |
Chief Executive Officer (CEO) |
Roche (Group) |
Switzerland |
Schwandner, Ralf Thomas (Assay.Works GmbH 201607– Managing Director (CEO) + Co-Founder before Amgen Research GmbH) |
Managing Director |
Assay.Works GmbH |
Germany |
Schwandner, Wolfgang (Arnika Beteiligungen 201703 Managing Director) |
Managing Director |
Arnika Beteiligungen GmbH (family office) |
Germany |
Schwaneberg, Ulrich (RWTH Aachen 2009– Professor before Jacobs Univ Bremen Professor) |
Professor |
RWTH Aachen (Rheinisch-Westfälische Technische Hochschule Aachen) |
Germany |
Schwartz, Jared N. (Danaher 201307 CMO at Leica Biosystems) |
Chief Medical Officer (CMO) |
Danaher (Group) |
Germany |
Schwartz, Stephan, Gero (Univ Regensburg 200705 Institute for Pathology) |
Researcher (university / research institute) |
University of Regensburg, Institute for Pathology (IPUR) |
Germany |
Schwartz, Stephen S. (Steve) (Brooks Automation 201107 CEO) |
Chief Executive Officer (CEO) |
Brooks Automation (Group) |
United States (USA) |
Schwartz, Véronique (BASF 202005 team leader at faCellitate project of Chemovator GmbH) |
n. a. |
BASF (Group) |
Germany |
Schwarz, Christian (Numaferm GmbH 201702– Managing Director) |
Managing Director |
Numaferm GmbH |
Germany |
Schwarz, Gerold (Biotecon 201701– Product Manager before Analytik Jena + Bruker Datlonics + PANATecs) |
Product Manager (personnel) |
Zukunftsfonds Heilbronn (Group) |
Germany |
Schwarz, Harald |
n. a. |
Medical Strategy GmbH |
Germany |
Schwarz, Karin (Bruker201401 Direct Marketing Manager MALDI Biotyper) |
Sales Manager / Marketing Manager |
Bruker (Group) |
Germany |
Schwarz, Otto (Actelion 201106– COO before Head Business Strategy + Operations since 2008) |
Chief Operating Officer (COO) |
Johnson & Johnson (JnJ) (Group) |
Switzerland |
Schwarz, Rainer (Cunesoft GmbH 201410 Managing Director (CEO)) |
Managing Director |
Phlexglobal (Group) |
Germany |
Schwarz, Sigrid (NeuroProgen 200601 CEO) |
Chief Executive Officer (CEO) |
NeuroProgen GmbH |
Germany |
Schwarz, Thomas (Instraction GmbH 2009– Managing Director + Board Chairman CLIB2021 before Biotop AG) |
Managing Director |
InstrAction GmbH |
Germany |
Schwarz-Schütte, Patrick (Schwarz Pharma) |
Chief Executive Officer (CEO) |
UCB (Group) |
Germany |
Schwarzkopf, Martina (Russo Partners 201312) |
Public Relations Manager / Investor Relations Manager |
Russo Partners LLC |
United States (USA) |
Schweickart, Nikolaus (Altana AG 200605 CEO) |
Chief Executive Officer (CEO) |
Altana (Group) |
Germany |
Schweickhardt, Wolfram (Germany (govt) 201505 at KfW) |
n. a. |
Germany (govt) |
Germany |
Schweiger, Christian (Shield Therapeutics 2008– CSO + Co-founder before Encysive Pharmaceuticals before Actelion) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Iron Therapeutics (Switzerland) AG |
Switzerland |
Schweikhard, Lutz (Univ Greifswald 201007 Professor + Director of Institute of Physics) |
Professor |
University of Greifswald |
Germany |
Schweins, Thomas (Qiagen 200402– VP Corporate Strategy before Boston Consulting Dusseldorf before Hoechst) |
Corporate Strategy Manager |
Qiagen (Group) |
Netherlands |
Schweitzer, Gretchen (Trophic Comunications 201801 before MacDougall European Office) |
Public Relations Manager / Investor Relations Manager |
Trophic Communications GmbH |
Germany |
Schweitzer, Markus |
n. a. |
Sanofi (Group) [since May 2011] |
Germany |
Schweizer, Christoph (Dräger 201801 President Corporate Strategy + Business Development) |
Business Development Manager / Strategy Manager |
Dräger (Group) |
Germany |
Schweizer, Pascal (Thermosome GmbH 201604 Managing Director) |
Managing Director |
Thermosome GmbH |
Germany |
Schwenzer, Anette (Promega 201101 Promega GmbH Head Digital Marketing/PR) |
Sales Manager / Marketing Manager |
Promega (Group) |
Germany |
Schwer, Heinz (ViraTherapeutics 201705– CEO before Lanthio Pharma + Sloning BioTechnology CEO + Founder) |
Chief Executive Officer (CEO) |
Boehringer Ingelheim (Group) |
Austria |
Schwerin, Manfred (Leibniz-Gemeinschaft 201109 Head FBN Dummerstorf) |
President/Director/Head Business Group/Unit/Division |
Leibniz-Gemeinschaft |
Germany |
Schwertner-Knoll, Dagmar (BioGenes GmbH 201302 Marketing/Sales Director) |
Sales Manager / Marketing Manager |
BioGenes Gesellschaft für Biopolymere mbH (BioGenes GmbH) |
Germany |
Schwiezer, Jürgen (Roche Diagnostics GmbH –200605– designated CEO Division Roche Diagnostics 200801) |
Chief Executive Officer (CEO) |
Roche (Group) |
Germany |
Schüberg, Staffan (Esteve 202001 CEO before Lundbeck) |
Chief Executive Officer (CEO) |
Esteve (Group) |
Spain (España) |
Schühsler, Helmut M. (TVM) |
n. a. |
TVM (Group) |
Germany |
Schülein, Thomas (Bruker 201308 President of Bruker Nano Analytics division) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
|
Schüler, Julia (BioMedServices 201101– before BioRegion Rhein-Neckar 200910–201012 Managing Director + E&Y Mannheim) |
consulting (economic) |
BioMedServices, Dr. Julia Schüler |
Germany |
Schüller, Alexander (Cellvie 202101 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Cellvie (Group) |
Switzerland |
Schüller, Frank (Forever Healthy 202101 Managing Director of Kizoo Technology Capital) |
Managing Director |
Forever Healthy (Group) |
|
Schüller, Thorsten (CureVac 201911 Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
CureVac (Group) |
Germany |
Schüller, Ulrich |
n. a. |
LMU Munich (Ludwig-Maximilians-Universität München, University of Munich) |
Germany |
Schüller, Wolfgang (Lipotec GmbH + Frankfurt BioTech Alliance e. V. before Aventis Research and Technologies 200205) |
Managing Director |
Sanofi (Group) [since May 2011] |
Germany |
Schüren, Reinhard (November AG 200609– CEO) |
Chief Executive Officer (CEO) |
November (Group) |
Germany |
Schürmann, Anja (Biofrontera 200801– Director Marketing before Galderma) |
Sales Manager / Marketing Manager |
Biofrontera (Group) |
Germany |
Schürmann, Hans |
n. a. |
Holtzbrinck (Group) |
|
Schütte, Georg (BMBF 201202 State Sectretary) |
Administrative Officer (personnel) |
Germany (govt) |
Germany |
Schütte, Stefan (Agilent 200903 Senior Marketing Director Liquid Chromatography Business) |
Sales Manager / Marketing Manager |
Agilent (Group) |
United States (USA) |
Schütz, Christian (btov Partners 201907 Managing Director) |
Managing Director |
btov Partners (b-to-v Partners AG) |
Switzerland |
Schütze, Karin (CellTool GmbH 201912 Managing Director + Co-Founder) |
Managing Director |
CellTool GmbH |
Germany |
Schüßler, Andrea (Huber & Schüßler 200809 Munich) |
n. a. |
Huber & Schüssler Patentanwälte (Munich) |
Germany |
Schächtele, Christoph (ProQinase 200805 CEO) |
Chief Executive Officer (CEO) |
Klinik für Tumorbiologie Freiburg (KTB) (Tumor Biology Center Freiburg) |
Germany |
Schäfer, Bernd-Josef (Endress+Hauser 201801 Managing Director of Endress+Hauser Flowtec) |
Managing Director |
Endress+Hauser (Group) |
Switzerland |
Schäfer, Elmar (Biogenerix 200503) |
n. a. |
Merckle (Group) |
Germany |
Schäfer, Gerhard (Novartis/Sandoz + before Hexal + Stada + Noll + Azupharma) |
n. a. |
Novartis (Group) |
Germany |
Schäfer, Gisbert (AB SCIEX 201009 Senior Director EMEA) |
Regional manager |
Danaher (Group) |
Germany |
Schäfer, Jochen (GATC Biotech 201011 Director Custom Sequencing) |
Laboratory Manager (industry) |
Eurofins (Group) |
Germany |
Schäfer, Klaus (Altana Pharma 200503) |
n. a. |
Takeda (Group) |
Germany |
Schäfer, Mathias (Univ Cologne 201004 Head Mass Spec Lab at Institute for Organic Chemistry) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
University of Cologne (Universität zu Köln) |
Germany |
Schäfer, Ralf (Bruker Corp 201303 Bruker Daltonics MADI-TOF Product Manager) |
Product Manager (personnel) |
Bruker (Group) |
Germany |
Schäfer-Korting, Monika (FU Berlin 200507) |
n. a. |
Freie Universität Berlin (FU Berlin, Free University Berlin) |
Germany |
Schäferkordt, Jan |
n. a. |
Miltenyi Biotec (Group) |
Germany |
Schäffer, Michael (Probiodrug 201810– CBO joined 201808 as EVP Business + Strategy before Crelux + Sireen) |
Business Development Manager / Strategy Manager |
Vivoryon (Group) |
Germany |
Schöfer, Sebastian (High-Tech Gründerfonds 201409 Investment Manager) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
Schön, Heiko (Merck (DE) 201508– Manager Group Strategy joined Merck in 2005) |
Corporate Strategy Manager |
Merck (DE) (Group) |
Germany |
Schön-Feltes, Silvia (NRW 201010 PROvendis responsible for Biology) |
IP Manager |
Provendis (Patentagentur NRW) |
Germany |
Schönauer, David (Aminoverse 202003– CEO before SeSaM-Biotech GmbH 201212–202002 Managing Director) |
Chief Executive Officer (CEO) |
Aminoverse B.V. |
Netherlands |